Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
Invitae United States | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
CYP11B2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Congenital Adrenal Hyperplasia (CAH) Panel Centogene AG - the Rare Disease Company Germany | 12 | 12 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Aldosterone to renin ratio raised (CYP11B2 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 527 | 338 |
|
Baylor Genetics United States | 842 | 637 |
|
Monogenic Hypertension Genetic Panel MNG Laboratories (Medical Neurogenetics, LLC.) United States | 16 | 11 |
|
Natera, Inc. United States | 244 | 254 |
|
Natera, Inc. United States | 103 | 107 |
|
Natera, Inc. United States | 103 | 106 |
|
Natera, Inc. United States | 265 | 275 |
|
Natera, Inc. United States | 265 | 274 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.